Skip to main content
Evolving treatment paradigms in sickle cell disease.
Chronic organ failure in adult sickle cell disease.
Emerging 'A' therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine.
Alpha thalassemia major--new mutations, intrauterine management, and outcomes.
Non-invasive assessment of tissue iron overload.
Stem cell therapy for sickle cell disease: transplantation and gene therapy.
Immunodeficiency disorders.
Bone Marrow Transplantation for Non-Malignant Disease.